| Date Filed | Type | Description |
| 08/14/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 08/08/2023 |
SC 13G/A
| FEDERATED HERMES, INC. reports a 4.4% stake in ANNEXON, INC. |
| 08/02/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/02/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/27/2023 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data |
| 07/07/2023 |
SC 13G/A
| BlackRock Inc. reports a 8.8% stake in FEDERATED HERMES, INC |
| 07/03/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/16/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/09/2023 |
SC 13G/A
| FEDERATED HERMES, INC. reports a 3.9% stake in MALLINCKRODT PLC |
| 06/09/2023 |
SC 13G/A
| FEDERATED HERMES, INC. reports a 16.7% stake in FUSION PHARMACEUTICALS, INC. |
| 05/26/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/26/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/11/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/10/2023 |
SC 13G/A
| FEDERATED HERMES, INC. reports a 9% stake in SERES THERAPEUTICS, INC. |
| 05/10/2023 |
SC 13G/A
| FEDERATED HERMES, INC. reports a 19.9% stake in REGULUS THERAPEUTICS, INC. |
| 05/08/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/04/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/03/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/02/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 04/27/2023 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data |
| 03/15/2023 |
DEF 14C
| Form DEF 14C - Other definitive information statements: |
| 03/10/2023 |
SC 13G/A
| FEDERATED HERMES, INC. reports a 4.6% stake in MERUS, N.V. |
| 03/10/2023 |
SC 13G/A
| FEDERATED HERMES, INC. reports a 4.7% stake in ARIS WATER SOLUTIONS, INC. |
| 02/24/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 02/13/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/09/2023 |
SC 13G/A
| VANGUARD GROUP INC reports a 9.5% stake in Federated Hermes Inc. Class B |
| 02/09/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/09/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/09/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/01/2023 |
SC 13G/A
| FEDERATED HERMES, INC. reports a 6.8% stake in XPONENTIAL FITNESS, INC. |
| 02/01/2023 |
SC 13G/A
| FEDERATED HERMES, INC. reports a 10.8% stake in SHOTSPOTTER, INC. |
| 02/01/2023 |
SC 13G/A
| FEDERATED HERMES, INC. reports a 14.5% stake in SERES THERAPEUTICS, INC. |
| 02/01/2023 |
SC 13G/A
| FEDERATED HERMES, INC. reports a 20% stake in SCYNEXIS, INC. |
| 02/01/2023 |
SC 13G/A
| FEDERATED HERMES, INC. reports a 11.2% stake in RHYTHM PHARMACEUTICALS, INC. |
|